Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist (Q42603760)

3 November 2017

Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist (English)

1 reference

3 November 2017

5

George F Koob

1 reference

3 November 2017

Glenn R Valdez

1

1 reference

3 November 2017

Eric P Zorrilla

series ordinal

2

1 reference

3 November 2017

Jean Rivier

series ordinal

3

1 reference

3 November 2017

Wylie W Vale

series ordinal

4

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

3 November 2017

1 reference

3 November 2017

980

1 reference

3 November 2017

2

1 reference

3 November 2017

206-212

1 reference

Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety.

3 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Restraint and stimulation of bed nucleus of the stria terminalis produce similar stress-like behaviors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Stress-induced sensitization to amphetamine and morphine psychomotor effects depend on stress-induced corticosterone secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

The effect of single and repeated electroconvulsive shock (ECS) on locomotor activity in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Lesions of the bed nucleus of the stria terminalis block sensitization of the acoustic startle reflex produced by repeated stress, but not fear-potentiated startle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Corticotropin releasing factor mRNA expression in the hypothalamic paraventricular nucleus and the central nucleus of the amygdala is modulated by repeated acute stress in the immature rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Effects of Alpha-Flupenthixol and Naloxone on CRF-Induced Locomotor Activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

CRF antagonist partially reverses CRF- and stress-induced effects on feeding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Lateral and medial septal lesions reduce anxiety in the plus-maze and probe-burying tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Appetite-suppressing effects of urocortin, a CRF-related neuropeptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Stress- and corticosteroid-induced modulation of the locomotor response to morphine in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Corticotropin releasing factor produces behavioural activation in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

The role of the lateral septum in anxiolysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902971-8

10.1016/S0006-8993(03)02971-8

7 January 2021

Identifiers

DOI

1 reference

3 November 2017

1 reference